NLRP3 and lupus nephritis: For instance, Tsai et al. [46] observed that the flavonoid gallocatechin gallate (EGCG) attenuated lupus nephritis in mice by inhibiting caspase-1 activation through decreased NLRP3 mRNA expression, reducing IL-1β and IL-18 production.